Oric Pharmaceuticals Inc
ORIC12.530USD
-0.160-1.26%
交易中 （美东）报价延迟15分钟
1.08B总市值
亏损市盈率 TTM
关于 Oric Pharmaceuticals Inc 公司
ORIC Pharmaceuticals, Inc. 是一家临床阶段的生物制药公司，致力于通过克服癌症耐药性来改善患者的生活。该公司正在开发一系列临床和发现阶段的疗法，旨在通过利用其在三个特定领域的专业知识来对抗癌症的耐药机制：激素依赖性癌症、精准肿瘤学和关键肿瘤依赖性。其临床阶段候选产品包括 ORIC-114，一种脑渗透抑制剂，旨在选择性靶向 EGFR 和 HER2，对外显子 20 插入突变具有高效力，正在针对多种基因定义的癌症进行开发；ORIC-944，一种通过 EED 亚基的多梳抑制复合物 2 (PRC2) 的变构抑制剂，正在为前列腺癌开发；以及 ORIC-533，一种口服生物可利用的小分子 CD73 抑制剂，CD73 是腺苷通路中的一个关键节点，被认为在化疗和免疫疗法治疗方案的耐药性中起着核心作用。
Oric Pharmaceuticals Inc简介
公司代码ORIC
公司名称Oric Pharmaceuticals Inc
上市日期Apr 24, 2020
CEODr. Jacob M. Chacko, M.D.
员工数量115
证券类型Ordinary Share
年结日Apr 24
公司地址240 E. Grand Ave
城市SOUTH SAN FRANCISCO
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编94080
电话16503885600
网址https://oricpharma.com/
公司代码ORIC
上市日期Apr 24, 2020
CEODr. Jacob M. Chacko, M.D.
Oric Pharmaceuticals Inc公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Jacob M. Chacko, M.D.
Dr. Jacob M. Chacko, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
528.65K
-14.61%
Dr. Richard A. (Rich) Heyman, Ph.D.
Dr. Richard A. (Rich) Heyman, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
261.57K
+14.34%
Dr. Kevin Brodbeck, Ph.D.
Dr. Kevin Brodbeck, Ph.D.
Chief Technical Officer
Chief Technical Officer
--
--
Mr. Dominic G. Piscitelli, CPA
Mr. Dominic G. Piscitelli, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Pratik S. Multani, M.D.
Dr. Pratik S. Multani, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Mardi C. Dier
Ms. Mardi C. Dier
Independent Director
Independent Director
--
--
Mr. Steven L. (Steve) Hoerter
Mr. Steven L. (Steve) Hoerter
Independent Director
Independent Director
--
--
Dr. Lori A. Kunkel, M.D.
Dr. Lori A. Kunkel, M.D.
Independent Director
Independent Director
--
--
Dr. Angie J. You, Ph.D.
Dr. Angie J. You, Ph.D.
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Jacob M. Chacko, M.D.
Dr. Jacob M. Chacko, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
528.65K
-14.61%
Dr. Richard A. (Rich) Heyman, Ph.D.
Dr. Richard A. (Rich) Heyman, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
261.57K
+14.34%
Dr. Kevin Brodbeck, Ph.D.
Dr. Kevin Brodbeck, Ph.D.
Chief Technical Officer
Chief Technical Officer
--
--
Mr. Dominic G. Piscitelli, CPA
Mr. Dominic G. Piscitelli, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Pratik S. Multani, M.D.
Dr. Pratik S. Multani, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Mardi C. Dier
Ms. Mardi C. Dier
Independent Director
Independent Director
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 8月31日 周日
更新时间: 8月31日 周日
持股股东
股东类型
持股股东
持股股东
占比
Nextech Invest, Ltd.
7.37%
EcoR1 Capital, LLC
6.93%
VR Adviser, LLC
6.79%
Viking Global Investors LP
6.77%
Pfizer Inc
5.54%
其他
66.60%
持股股东
持股股东
占比
Nextech Invest, Ltd.
7.37%
EcoR1 Capital, LLC
6.93%
VR Adviser, LLC
6.79%
Viking Global Investors LP
6.77%
Pfizer Inc
5.54%
其他
66.60%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
28.79%
Investment Advisor
26.63%
Venture Capital
22.65%
Hedge Fund
14.71%
Corporation
5.54%
Private Equity
2.02%
Sovereign Wealth Fund
1.98%
Research Firm
1.23%
Individual Investor
1.21%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
297
95.41M
98.24%
+8.51M
2025Q2
288
93.19M
110.15%
+12.20M
2025Q1
294
83.96M
99.59%
+456.78K
2024Q4
284
80.39M
113.18%
-3.73M
2024Q3
272
78.70M
112.04%
-2.29M
2024Q2
265
76.25M
113.03%
-1.57M
2024Q1
276
71.21M
105.62%
-1.02M
2023Q4
259
57.91M
108.09%
+1.21M
2023Q3
260
55.20M
103.62%
-1.09M
2023Q2
255
52.76M
117.11%
+8.95M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Nextech Invest, Ltd.
7.16M
7.37%
+1.88M
+35.51%
Jun 30, 2025
EcoR1 Capital, LLC
6.73M
6.93%
+5.11M
+315.81%
Jul 29, 2025
VR Adviser, LLC
6.60M
6.79%
--
--
Jun 30, 2025
Viking Global Investors LP
6.57M
6.77%
--
--
Jun 30, 2025
Pfizer Inc
5.38M
5.54%
--
--
Jun 30, 2025
SR One Capital Management, LP
4.62M
4.75%
+100.45K
+2.22%
Aug 12, 2025
New Enterprise Associates (NEA)
4.12M
4.24%
+1.92M
+87.59%
Jun 30, 2025
Alkeon Capital Management LLC
3.75M
3.86%
+409.32K
+12.25%
Jun 30, 2025
The Column Group LP
3.54M
3.65%
--
--
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
3.43M
3.53%
-969.78K
-22.06%
Jun 30, 2025
查看更多
持股ETF
更新时间: 11月2日 周日
更新时间: 11月2日 周日
机构名称
占比
iShares Genomics Immunology and Healthcare ETF
1.08%
Virtus LifeSci Biotech Clinical Trials ETF
0.9%
SPDR S&P Biotech ETF
0.26%
Optimize Strategy Index ETF
0.25%
iShares Health Innovation Active ETF
0.15%
Direxion Daily S&P Biotech Bull 3X Shares
0.15%
iShares Micro-Cap ETF
0.15%
ProShares Ultra Nasdaq Biotechnology
0.12%
Invesco Nasdaq Biotechnology ETF
0.12%
Fidelity Enhanced Small Cap ETF
0.08%
查看更多
iShares Genomics Immunology and Healthcare ETF
占比1.08%
Virtus LifeSci Biotech Clinical Trials ETF
占比0.9%
SPDR S&P Biotech ETF
占比0.26%
Optimize Strategy Index ETF
占比0.25%
iShares Health Innovation Active ETF
占比0.15%
Direxion Daily S&P Biotech Bull 3X Shares
占比0.15%
iShares Micro-Cap ETF
占比0.15%
ProShares Ultra Nasdaq Biotechnology
占比0.12%
Invesco Nasdaq Biotechnology ETF
占比0.12%
Fidelity Enhanced Small Cap ETF
占比0.08%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
